Kirilys Therapeutics
PrivateLast Round
VC Round
Jan 25, 2023
Company Overview
Kirilys Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a VC Round in January 2023.
Kirilys Therapeutics is a biotechnology company that develops precision oncology assets, including CDK7 inhibitors and antibody-drug conjugates, for the treatment of various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kirilys Therapeutics Comparables
Compare Kirilys Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Edgewood Oncology | 87% | |
| Carrick Therapeutics | 83% | |
| Avenzo Therapeutics | 81% |
For institutional investors. Book with your work email.
Kirilys Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 25, 2023 | ||||
| Seed | Mar 23, 2022 |
For institutional investors. Book with your work email.
Kirilys Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Brain Corporation | VC Round |
| Catalys Pacific | Seed |
| Lightspeed Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 25, 2023
Funding round included KDDI and Global Brain Corporation.
- Mar 23, 2022
Led by Lightspeed Venture Partners with participation from Catalys Pacific.
For institutional investors. Book with your work email.
Kirilys Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kirilys Therapeutics's valuation, stock price, and market status.
Is Kirilys Therapeutics a public or private company?
Kirilys Therapeutics is a private company.
What is the current stock price of Kirilys Therapeutics?
Kirilys Therapeutics is a private company, so its shares have no public market price. Caplight tracks Kirilys Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kirilys Therapeutics worth (valuation)?
Valuation information for Kirilys Therapeutics is not publicly available.
Can I buy Kirilys Therapeutics stock?
Kirilys Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kirilys Therapeutics's last funding round?
Kirilys Therapeutics's most recent funding round was VC Round on January 25, 2023.
Who are the main investors in Kirilys Therapeutics?
Key investors in Kirilys Therapeutics include Lightspeed Venture Partners.
Will Kirilys Therapeutics IPO soon?
No public IPO plans have been announced for Kirilys Therapeutics.
How can I track Kirilys Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Kirilys Therapeutics's shares on secondary markets.